Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

Nature Chemical Biology

Volumn 6, Issue 3, 2010, Pages 209-217

  Schneider Poetsch, Tilman ^a   Ju, Jianhua ^b   Eyler, Daniel E ^a   Dang, Yongjun ^a   Bhat, Shridhar ^a   Merrick, William C ^c   Green, Rachel ^a   Shen, Ben ^b   Liu, Jun O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYTIDINE; DORRIGOCIN; GLUTARIMIDE DERIVATIVE; ISOMIGRASTATIN; LACTIMIDOMYCIN; MIGRASTATIN; NUCLEOTIDE; TRANSFER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG BINDING SITE; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RIBOSOME SUBUNIT; RNA TRANSPORT; TRANSLATION REGULATION; TUMOR CELL LINE; YEAST;

EUKARYOTA;

EID: 77249087063     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.304     Document Type: Article

References (42)

1. Poehlsgaard, J. & Douthwaite, S. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3, 870-881 (2005).
2. Obrig, T.G., Culp, W.J., McKeehan, W.L. & Hardesty, B. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 246, 174-181 (1971).
3. Pestova, T.V. & Hellen, C.U. Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. Genes Dev. 17, 181-186 (2003).
4. Ju, J., Lim, S.K., Jiang, H., Seo, J.W. & Shen, B. Iso-migrastatin congeners from Streptomyces platensis and generation of a glutarimide polyketide library featuring the dorrigocin, lactimidomycin, migrastatin, and NK30424 scaffolds. J. Am. Chem. Soc. 127, 11930-11931 (2005).
5. Sugawara, K. et al. Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity. J. Antibiot. (Tokyo) 45, 1433-1441 (1992).
6. Gaul, C. et al. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. J. Am. Chem. Soc. 126, 11326-11337 (2004).
7. Shan, D. et al. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc. Natl. Acad. Sci. USA 102, 3772-3776 (2005).
8. Kadam, S. & McAlpine, J.B. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. III. Biological properties and mechanism of action. J. Antibiot. (Tokyo) 47, 875-880 (1994). (Pubitemid 24276679)
9. Karwowski, J.P. et al. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. I. Taxonomy of the producing organism, fermentation and biological activity. J. Antibiot. (Tokyo) 47, 862-869 (1994).
10. Ju, J., Lim, S.K., Jiang, H. & Shen, B. Migrastatin and dorrigocins are shunt metabolites of iso-migrastatin. J. Am. Chem. Soc. 127, 1622-1623 (2005).
11. Feng, Z. et al. Engineered production of iso-migrastatin in heterologous Streptomyces hosts. Bioorg. Med. Chem. 17, 2147-2153 (2009).
12. Nakae, K. et al. Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. (Tokyo) 53, 1130-1136 (2000a).
13. Nakae, K. et al. Migrastatin, a novel 14-membered lactone from Streptomyces sp. MK929-43F1. J. Antibiot. (Tokyo) 53, 1228-1230 (2000).
14. Fried, H.M. & Warner, J.R. Molecular cloning and analysis of yeast gene for cycloheximide resistance and ribosomal protein L29. Nucleic Acids Res. 10, 3133-3148 (1982).
15. Kaufer, N.F., Fried, H.M., Schwindinger, W.F., Jasin, M. & Warner, J.R. Cycloheximide resistance in yeast: the gene and its protein. Nucleic Acids Res. 11, 3123-3135 (1983).
16. Planta, R.J. & Mager, W.H. The list of cytoplasmic ribosomal proteins of Saccharomyces cerevisiae. Yeast 14, 471-477 (1998).
17. Stevens, D.R., Atteia, A., Franzen, L.G. & Purton, S. Cycloheximide resistance conferred by novel mutations in ribosomal protein L41 of Chlamydomonas reinhardtii. Mol. Gen. Genet. 264, 790-795 (2001).
18. Kawai, S. et al. Drastic alteration of cycloheximide sensitivity by substitution of one amino acid in the L41 ribosomal protein of yeasts. J. Bacteriol. 174, 254-262 (1992).
19. Robert, F. et al. Altering chemosensitivity by modulating translation elongation. PLoS One 4, e5428 (2009).
20. Tai, P.C., Wallace, B.J. & Davis, B.D. Selective action of erythromycin on initiating ribosomes. Biochemistry 13, 4653-4659 (1974).
21. Anthony, D.D. & Merrick, W.C. Analysis of 40 S and 80 S complexes with mRNA as measured by sucrose density gradients and primer extension inhibition. J. Biol. Chem. 267, 1554-1562 (1992).
22. Jan, E. & Sarnow, P. Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. J. Mol. Biol. 324, 889-902 (2002).
23. Novac, O., Guenier, A.S. & Pelletier, J. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res. 32, 902-915 (2004).
24. Algire, M.A. & Lorsch, J.R. Where to begin? The mechanism of translation initiation codon selection in eukaryotes. Curr. Opin. Chem. Biol. 10, 480-486 (2006).
25. Kapp, L.D. & Lorsch, J.R. The molecular mechanics of eukaryotic translation. Annu. Rev. Biochem. 73, 657-704 (2004).
26. Bordeleau, M.E. et al. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. USA 102, 10460-10465 (2005).
27. Rodnina, M.V. et al. Mechanism of tRNA translocation on the ribosome. Mol. Biol. (Mosk.) 35, 655-665 (2001).
28. Merrick, W.C. Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56, 291-315 (1992).
29. Lorsch, J.R. & Herschlag, D. Kinetic dissection of fundamental processes of eukaryotic translation initiation in vitro. EMBO J. 18, 6705-6717 (1999).
30. Saini, P., Eyler, D.E., Green, R. & Dever, T.E. Hypusine-containing protein eIF5A promotes translation elongation. Nature 459, 118-121 (2009).
31. Holmberg, L., Melander, Y. & Nygard, O. Probing the structure of mouse Ehrlich ascites cell 5.8S, 18S and 28S ribosomal RNA in situ. Nucleic Acids Res. 22, 1374-1382 (1994).
32. Chandramouli, P. et al. Structure of the mammalian 80S ribosome at 8.7 A resolution. Structure 16, 535-548 (2008).
33. Cannone, J.J. et al. The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics 3, 2 (2002).
34. Moazed, D. & Noller, H.F. Interaction of tRNA with 23S rRNA in the ribosomal A, P, and E sites. Cell 57, 585-597 (1989).
35. Ledoux, S. & Uhlenbeck, O.C. [3′-32P]-labeling tRNA with nucleotidyltransferase for assaying aminoacylation and peptide bond formation. Methods 44, 74-80 (2008).
36. Lill, R., Robertson, J.M. & Wintermeyer, W. Binding of the 3′ terminus of tRNA to 23S rRNA in the ribosomal exit site actively promotes translocation. EMBO J. 8, 3933-3938 (1989).
37. Ruggero, D. & Pandolfi, P.P. Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179-192 (2003).
38. Rinehart, K.L. Antitumor compounds from tunicates. Med. Res. Rev. 20, 1-27 (2000).
39. SirDeshpande, B.V. & Toogood, P.L. Mechanism of protein synthesis inhibition by didemnin B in vitro. Biochemistry 34, 9177-9184 (1995).
40. Acker, M.G., Kolitz, S.E., Mitchell, S.F., Nanda, J.S. & Lorsch, J.R. Reconstitution of yeast translation initiation. Methods Enzymol. 430, 111-145 (2007).
41. Smith, C.W.J. RNA-Protein Interactions: a Practical Approach (Oxford University Press, 1998).
42. Holmberg, L., Melander, Y. & Nygard, O. Probing the conformational changes in 5.8S, 18S and 28S rRNA upon association of derived subunits into complete 80S ribosomes. Nucleic Acids Res. 22, 2776-2783 (1994).